| Bioactivity | CMKLR1 antagonist 1 (compound S-26d) is a potent and orally active chemokine-like receptor 1 (CMKLR1) antagonist, with a pIC50 value of 7.44 in hCMKLR1-transfected CHO cells. CMKLR1 antagonist 1 can be used for psoriasis and metabolic diseases research[1]. |
| Name | CMKLR1 antagonist 1 |
| Formula | C30H29Cl2FN2O4 |
| Molar Mass | 571.47 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Ko B, et al. Discovery of 3-Phenyl Indazole-Based Novel Chemokine-like Receptor 1 Antagonists for the Treatment of Psoriasis. J Med Chem. 2023 Oct 26. |
CMKLR1 antagonist 1
CAS: F: C30H29Cl2FN2O4 W: 571.47
CMKLR1 antagonist 1 (compound S-26d) is a potent and orally active chemokine-like receptor 1 (CMKLR1) antagonist, with a
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.